Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 37Lung Neoplasms 21Brain Neoplasms 21Prostatic Neoplasms 20Pancreatic Neoplasms 20Neoplasm Metastasis 20Carcinoma, Hepatocellular 17Melanoma 15Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Small Cell Lung Carcinoma 6Liver Neoplasms 6Glioblastoma 6Sarcoma 5Head and Neck Neoplasms 4Salivary Gland Neoplasms 3Recurrence 3Kidney Neoplasms 3Gliosarcoma 3Glioma 3Colorectal Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma of Lung 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Ewing 2

Interventions

pembrolizumab 26atezolizumab 14Nivolumab 13Gemcitabine 13Cisplatin 10Docetaxel 8Carboplatin 8avelumab 7Mitomycin 7epacadostat 4cabozantinib 4Ipilimumab 4pemigatinib 3Specimen Handling 3Paclitaxel 3Magnetic Resonance Spectroscopy 3Bevacizumab 3vofatamab 2rucaparib 2lenvatinib 2enfortumab vedotin 2durvalumab 2cabazitaxel 2bempegaldesleukin 2Standard of Care 2Rogaratinib 2Ramucirumab 2Radiation 2Platinum 2Pemetrexed 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Transitional Cell × Radiosurgery × Clear all
NCT04936230 2025-08-17

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
1 enrolled 1 chart
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡